In vivo antimalarial activity of methanol leaf extract of Bombax buonopozense in mice infected with Plasmodium berghei

Bombax buonopozense is used in ethnomedical practice for the treatment of fever. The methanol leaf extract of this plant was evaluated for in vivo antiplasmodial activity against chloroquine sensitive plasmodium berghei in mice. The antiplasmodial effect during early and established infections was investigated. The extract (200-600 mg/kg, p.o) exhibited significant (P<0.05) antimalarial activity both in four-day early and in an established infection tests. The LD50 of the extract was established to be greater than 5000 mg/kg, p.o in mice. The result suggests that B. buonopozense leaf extract possesses significant (P< 0.05) antiplasmodial activity thus confirming its traditional use in malarial therapy.Keywords: Bombax buonopozense; Herbal medicine; Plasmodium berghei berghei; Mic

Anti-nociceptive, anti-inflammatory and antipyretic effects of the methanolic extract of Bombax buonopozense leaves in rats and mice

Methanolic extract of Bombax buonopozense was evaluated for possible anti-nociceptive, antiinflammatory and anti-pyretic activities in mice and rats. Acetic acid-induced abdominal constriction test in mice and formalin test in rats were used to investigate the antinociceptive effect of the extract. Studies were carried out on yeast-induced pyrexia and egg albumin-induced anti-inflammatory activity in rats. The extract produced a significant decrease in acetic acid-induced writhing in mice and inhibition of late phase of the formalin pain test in rats. The methanolic extract of B. buonopozense leaf also produced a potent antipyretic effect and significant inhibition of egg  albumin-induced antiinflammatory activity in rats. The result suggests that B. buonopozense contains biologically active substances with potential values for the treatment of fever, painful and inflammatory conditions.Keywords: Bombax buonopozense; analgesic, inflammation, pyrexia

Studies on anti-ulcer, analgesic and antipyretic properties of the ethanolic leaf extract of Gongronema latifolium in rodents

The ethanol extract of Gongronema latifolium leaves were evaluated for anti-ulcer, analgesic and anti pyretic activities in rats and mice. Ethanol-induced gastric ulceration, acetic acid-induced writhing and formalin-induced nociception were used. Yeast-induced hyperpyrexia was used to investigate the antipyretic activity. The extract produced a significant ulcer protective activity in rats. The extract also decreased pain induced both by acetic acid in mice and early phase of formalin test in rats. A significant reduction in hyperpyrexia was also produced by the extract in rats. This present studyprovides a strong evidence of anti-ulcer, analgesic and antipyretic activities of G. latifolium

Some haematological parametersin adult Nigerians with diabetes mellitus

No Abstract.Journal of Health and Visual Sciences Vol. 8 (2) 2006: pp. 5-6

Visual acuity pattern of adults in Elele, Rivers state, Nigeria

No Abstract.Journal of Health and Visual Sciences Vol. 9 (2) 2007: pp. 59-6

Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction

Hypoxia, or reduced oxygen, occurs in a variety of clinical and environmental situations. Hypoxic exposure is associated with decreased muscle mass and a concomitant reduction in exercise capacity, although the exact mechanisms are not completely understood. The activin type IIB receptor (ActRIIB) is a receptor for transforming growth factor-β (TGFβ) superfamily members that are involved in the negative regulation of lean tissue mass. Given that hypoxia has negative effects on muscle mass and function and that modulation of the ActRIIB has been shown to increase muscle mass, we tested the hypothesis that pharmacological targeting of the ActRIIB for 2 wk would attenuate the loss of muscle mass and function in mice after exposure to normobaric hypoxia. ActRIIB modulation was achieved using a soluble activin receptor/Fc fusion protein (sActRIIB) in mice housed in a hypoxic chamber for 1 or 2 wk. Hypoxia induced a reduction in body weight in PBS- and sActRIIB-treated mice, although sActRIIB-treated mice remained larger throughout the hypoxic exposure. The absolute forces generated by extensor digitorum longus muscles were also significantly greater in sActRIIB- than PBS-treated mice and were more resistant to eccentric contraction-induced force drop after eccentric lengthening contractions. In summary, sActRIIB pretreatment attenuated hypoxia-induced muscle dysfunction. These data suggest that targeting the ActRIIB is an effective strategy to counter hypoxia-induced muscle dysfunction and to preacclimatize to hypoxia in clinical or high-altitude settings